- DEAN FOR GLOBAL HEALTH
- PROFESSOR AND SYSTEM CHAIR Preventive Medicine
- PROFESSOR Pediatrics
American Board of Preventive Medicine
American Board of Pediatrics
- Environmental Pediatrics
- Exposure to toxic chemicals
- Lead Poisoning
- Pesticide Exposure
MD, Harvard Medical School
MetroHealth Medical Center
Children's Hospital Boston
Center for Disease Control
- Philip J. Landrigan, M.D., M.Sc., the Ethel H. Wise Professor of Preventive Medicine, is a pediatrician and epidemiologist. He has been a member of the faculty of Mount Sinai School of Medicine since 1985 and Chair of the Department of Preventive Medicine since 1990. He was named Dean for Global Health in 2010. Dr. Landrigan is also the Director of the Children's Environmental Health Center.
Dr. Landrigan graduated from Boston College in 1963 and from Harvard Medical School in 1967. He completed an internship in medicine/pediatrics at Cleveland Metropolitan General Hospital and a residency in pediatrics at Children's Hospital Boston. In 1977, he received a Diploma of Industrial Health from the University of London and a Masters of Science in Occupational Medicine degree from the London School of Hygiene and Tropical Medicine. He served for 15 years as an Epidemic Intelligence Service Officer and medical epidemiologist at the Centers for Disease Control and Prevention (CDC) and the National Institute for Occupational Safety and Health (NIOSH). While at CDC, Dr. Landrigan served for one year as a field epidemiologist in El Salvador and for much of another year in northern Nigeria. He participated in the Global Campaign for the Eradication of Smallpox. Dr. Landrigan directed the national program in occupational epidemiology for NIOSH. He was awarded the Meritorious Service Medal of the US Public Health Service.
In 1987, Dr. Landrigan was elected a member of the Institute of Medicine of the National Academy of Sciences. He served as Editor-in-Chief of the American Journal of Industrial Medicine and Editor of Environmental Research. He has published more than 500 scientific papers and 5 books. He has chaired committees at the National Academy of Sciences on Environmental Neurotoxicology and on Pesticides in the Diets of Infants and Children. From 1995 to 1997, Dr. Landrigan served on the Presidential Advisory Committee on Gulf War Veteran's Illnesses. In 1997-1998, Dr. Landrigan served as Senior Advisor on Children's Health to the Administrator of the U.S. Environmental Protection Agency and was instrumental in helping to establish a new Office of Children's Health Protection at EPA. From 2000-2002, Dr. Landrigan served on the Armed Forces Epidemiological Board. Dr Landrigan served from 1996 to 2005 in the Medical Corps of the United States Naval Reserve. He retired in 2005 at the rank of Captain. He continues to serve as Surgeon General of the New York Naval Militia, New York's Naval National Guard.
Dr. Landrigan is known for his many decades of work in protecting children against environmental threats to health. His research combines the tools of epidemiology with biological markers derived from clinical and laboratory medicine. Dr. Landrigan is deeply committed to translating research into strategies for health protection and disease prevention.
Dr. Landrigan is featured in the NY Times OpEd Why Are We Subsidizing Childhood Obesity?.
Frank R. Lautenberg Award in Public Health
University of Medicine and Dentistry of New Jersey
Stephen Smith Medal for Lifetime Achievement in Public Health
New York Academy of Medicine
Irving J. Selikoff Award
Alumni Award for Professional Excellence
Children's Environmental Health Champion Award
Environmental Protection Agency
Lifetime Achievement Award
Children's Health Environmental Coalition
Health Achievement in Occupational Medicine Award
American College of Occupational and Environmental Medicine
J. Lester Gabrilove Award
Mount Sinai School of Medicine
Jorma Rantanen Award
Finnish Institute for Occupational Health
David P. Rall Award for Advocacy in Public Health
American Public Health Association
James Keogh Award
National Institute for Occupational Safety and Health
Mount Sinai School of Medicine
Haven Emerson Award
Public Health Association of New York City
William Steiger Memorial Award
American Conference of Governmental Industrial Hygienists
Award for Environmental Advocacy on Behalf of Children
Environmental Advocates of New York
Katherine Boucot Sturgis Award
American College of Preventive Medicine
Vernon Houk Award
International Society for Occupational and Environmental Health
William Sidell Presidential Award
United Brotherhood of Carpenters
Herbert L. Needleman Medal and Award for Scientific Contributions and Advocacy on Behalf of Children
American Public Health Association
Occupational Health and Safety Award
International Association of Fire Fighters
Harriet Hardy Award
New England College of Occupational and Environmental Medicine
Institute of Medicine
New York Committee for Occupational Safety and Health
Dr. Landrigan’s landmark studies in the early 1970s of children exposed to lead near a lead ore smelter in El Paso, Texas were among the first to show that lead can cause brain damage to children at levels too low to cause clinically evident signs and symptoms – a phenomenon now termed “subclinical toxicity.” This work was critical in persuading the EPA to remove lead from gasoline and paint, actions that resulted in a 95% decline in lead poisoning in US children. This success has been emulated in nations worldwide.
The 1993 National Academy of Science report on Pesticides in the Diets of Infants and Children that Dr. Landrigan led provided the blueprint for the Food Quality Protection Act of 1996, the major law governing pesticide use in the US, and the only federal environmental law that contains explicit provisions for the protection of children’s health.
Dr. Landrigan has been a leader in developing and implementing the National Children's Study, the largest study of children's health and the environment ever launched in the United States. He has been centrally involved in the medical and epidemiologic studies that followed the destruction of the World Trade Center on September 11, 2001. He has consulted extensively to the World Health Organization.
In the News
Dr. Landrigan and his work were recently profiled in The Daily News feature The Daily Check Up. View the PDF. Dr. Landrigan was also profiled in The Lancet in 2005. View profile.
Read the commentary by Philip J. Landrigan, MD, MSc, "What's Getting Into Our Children?" that appeared in the New York Times on August 4, 2009.
Laborde A, Tomasina F, Bianchi F, Bruné MN, Buka I, Comba P, Corra L, Cori L, Duffert CM, Harari R, Iavarone I, McDiarmid MA, Gray KA, Sly PD, Soares A, Suk WA, Landrigan PJ. Children's Health in Latin America: The Influence of Environmental Exposures. Environmental health perspectives 2015 Mar; 123(3).
Landrigan PJ, Suk WA. Jenny Pronczuk de Garbino: A Global Champion for Children's Health. Environmental health perspectives 2015 Mar; 123(3).
Landrigan PJ, Fuller R. Environmental pollution: An enormous and invisible burden on health systems in low- and middle-income countries. World Hospitals and Health Services 2014; 50(4).
Laborde A, Tomasina F, Bianchi F, Bruné MN, Buka I, Comba P, Corra L, Cori L, Duffert CM, Harari R, Iavarone I, McDiarmid MA, Gray KA, Sly PD, Soares A, Suk WA, Landrigan PJ. Children's Health in Latin America: The Influence of Environmental Exposures. Environmental health perspectives 2014 Dec;.
Landrigan PJ, Fuller R. Environmental pollution and occupational health in a changing world. Annals of global health 2014 Jul-Aug; 80(4).
Sly PD, Neira M, Collman G, Carpenter DO, Landrigan PJ, Van Den Berg M, Barriga FD, Ruchirawat M, Laborde A, Pascale A, Heacock M, Dalmau MT, Suk WA. Networking to advance progress in children's environmental health. The Lancet. Global health 2014 Mar; 2(3).
Landrigan pj. What causes autism? Exploring the environmental contribution. Curr Opin Pediatr 2010; 22(2).
Fleisch a, Sheffield p, Chinn c, Edelstein b, Landrigan pj. Bisphenol A and Related Compounds in Dental Materials. Pediatrics 2010;.
Landrigan pj, Trasande l, Thorpe le. The National Children's Study: A 21-year prospective study of 100,000 American children. Pediatrics 2006; 118(5).
Grandjean p, Landrigan pj. Developmental Neurotoxicity of industrial chemicals: A silent pandemic. Lancet 2006; 368(9553).
Herbert r, Moline j, Skloot g, Metzger k, Baron s, Luft b, Markowitz s, Udasin i, Harrison d, Stein d, Todd a, Enright p, Stellman jm, Landrigan pj, Levin s. The World Trade Center Disaster and the Health of Workers: Five-Year Assessment of a Unique Medical Screening Program. Environ Health Perspect 2006; 114.
Landrigan pj, Lioy pj, Berkowitz G, Chen lc, Chillrud cn, Georgopoulos pg, Geyh as, Levin s, Perera f, Rappaport sm, Small c, Thurston g. Health and Environmental Consequences of the World Trade Center Disaster. Environ Health Perspect 2004; 112.
Landrigan pj, Schechter cb, Lipton jm, Fahs mc, Schwartz j. Environmental pollutants and disease in American children: Estimates of morbidity, mortality and costs for lead poisoning, asthma, cancer and developmental disabilities. Environ Health Perspect 2002; 110.
Landrigan pj, Carlson je. Environmental policy and children's health. The Future of Children 1995; 5.
Leigh jp, Markowitz sb, Fahs m, Shin c, Landrigan pj. Occupational injury and illness in the United States. Estimates of costs, morbidity, and mortality. Arch Intern Med 1997; 157.
Landrigan pj, Gehlbach sh, Rosenblum bf, Shoults jm, Candelaria rm, Barthel wf, Liddle ja, Smrek al, Staehling nw, Sanders jf. Epidemic lead absorption near an ore smelter: the role of particulate lead. New Engl J Med 1975; 292.
Landrigan pj, Whitworth rh, Baloh rw, Barthel wf, Staehling nw, Rosenblum bf. Neuropsychological dysfunction in children with chronic low-level lead absorption. Lancet 1975;.
Landrigan pj. Epidemic measles in a divided city. JAMA 1972 Aug; 221(6).
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Landrigan did not report having any of the following types of financial relationships with industry during 2014 and/or 2015: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Mount Sinai Health System (MSHS) physicians - including those employed by MSHS - do not always participate in the same health plans in which MSHS hospitals or facilities participate.
Information regarding insurance participation and billing by this physician may be found on this page or obtained by contacting this provider directly.
Insurance plans that the Mount Sinai Health System hospitals or facilities participate in can be found on the Mount Sinai Health System website.
17 East 102 Street
New York, NY 10029
17 East 102 Street Room D3-145
New York, NY 10029